#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal achalasia Haemophilia B without inhibitors Acute myeloid leukaemia (in remission) Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Non-Hodgkin's lymphoma refractory Sarcoma Primary biliary cholangitis Hepatitis D Fragile X syndrome Cutaneous T-cell lymphoma refractory Growth hormone deficiency Immune-mediated enterocolitis VEXAS syndrome Atypical haemolytic uraemic syndrome Follicular lymphoma More trials…

    Learn about Rare Diseases

    Turner’s syndrome Alexander disease – Life with Disease Mitochondrial myopathy – Treatment Inclusion body myositis – Basic Information Isodicentric chromosome 15 syndrome – Life with Disease Pituitary-dependent Cushing’s syndrome – Life with Disease Fabry’s disease – Basic Information Waldenstrom’s macroglobulinaemia refractory – Trials in Disease Methylmalonic acidaemia – Basic Information Prader-Willi syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bupropion Hydrochloride Pravastatin Sodium CARBACHOL Mocravimod BI-1607 Annamycin ANHYDROUS CALCIUM FOLINATE Nirogacestat Hydrobromide Darolutamide L-Threonine Povorcitinib Utreloxastat ARFOLITIXORIN Triheptanoin Hypromellose Calcium Polystyrene Sulfonate Tamsulosin Hydrochloride Sotorasib Levetiracetam Dasiglucagon More therapies…

    Learn about Your Condition

    Procedural pain Lymphangioleiomyomatosis Dystonia Rhinitis allergic Agitation postoperative Heart disease congenital Vasospasm Crigler-Najjar syndrome Androgenetic alopecia Delirium Herpes simplex Colon cancer stage IV Pigmentary glaucoma Escherichia infection Neurotrophic keratopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pneumonia

  • Study on High-Dose Short-Course Antibiotics for Critically Ill Patients with Pneumonia, Intra-Abdominal, or Bloodstream Infections: Ceftriaxone, Linezolid, and Cefotaxime

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Cefotaxime
    • Ceftriaxone Sodium
    • Cefuroxime Axetil
    Belgium The Netherlands
  • Study on the Effect of Amoxicillin in Preschool Children with Pneumonia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Amoxicillin Trihydrate
    Norway
  • Study on Amoxicillin and Clavulanic Acid for Treating Ventilator-Associated Pneumonia in Intensive Care Patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Amoxicillin
    • Clavulanic Acid
    France
  • Study on Dexamethasone and Sodium Chloride for Treating Severe Hospital-Acquired Pneumonia in Critically Ill Patients with a Proinflammatory Profile

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Dexamethasone Phosphate
    • Sodium Chloride
    Belgium France Greece Spain
  • Study on the Effects of Oseltamivir and Drug Combination for Patients with Pneumonia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Oseltamivir
    • Baloxavir Marboxil
    • Dexamethasone Ph. Eur.
    Belgium Estonia France Italy The Netherlands Portugal +3
  • Study on the Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine for Preventing Pneumonia in Adults Aged 65 and Older

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    • Pneumococcal Polysaccharide Serotype 10A Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    • Pneumococcal Polysaccharide Serotype 11A Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    Spain
1 2 3 … 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!